Cargando…

Fluorescence in situ hybridization (FISH) to predict the efficacy of Bacillus Calmette-Guérin perfusion in bladder cancer

BACKGROUND: Transurethral resection of bladder tumor (TURBT) combined with intravesical Bacillus Calmette-Guérin (BCG) perfusion is a widely accepted treatment for moderate or high risk non-muscular-invasive bladder cancer (BCa). Despite its effectiveness, the recurrence and progression rate of tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Chunjin, Liu, Zhenghao, Zhu, Junyu, Zeng, Xing, Hu, Zhiquan, Yang, Chunguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641077/ https://www.ncbi.nlm.nih.gov/pubmed/36388029 http://dx.doi.org/10.21037/tcr-22-1367

Ejemplares similares

The diagnostic value of fluorescence in situ hybridization in secondary electroresection of bladder cancer
por: Chen, Bowen, et al.
Publicado: (2023)

Microscopic detection of bacillus Calmette–Guérin mycobacteria in bladder biopsy using fluorescence in situ hybridization: Détection microscopique des Bacilles biliés de Calmette et Guérin (BCG) dans une biopsie vésicale par hybridation in situ en fluorescence
por: Loukil, A., et al.
Publicado: (2020)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

The role of fluorescence in situ hybridization to predict patient response to intravesical Bacillus Calmette–Guérin therapy for bladder cancer: A diagnostic meta-analysis and systematic review
por: Bao, Yige, et al.
Publicado: (2018)

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer
por: Rachakonda, Tara, et al.
Publicado: (2017)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
por: Miyazaki, Masashi, et al.
Publicado: (2016)

Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer
por: Liem, Esmee I. M. L., et al.
Publicado: (2017)

Renal metastases from esophageal cancer and retroperitoneal lymphoma detected via chromosome duplications identified by fluorescence in situ hybridization in urine exfoliated cells: First 2 case reports
por: Hu, Zhiquan, et al.
Publicado: (2021)

Systemic Granulomatous Reaction Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
por: Valentini, Caterina Giovanna, et al.
Publicado: (2012)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Fluorescence in situ hybridization microscopic detection of Bacilli Calmette Guérin mycobacteria in aortic lesions: A case report
por: Darriet, Florent, et al.
Publicado: (2018)

Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
por: Zhong, Wenlong, et al.
Publicado: (2020)

Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
por: Soylu, Aliye, et al.
Publicado: (2009)

Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
por: Madbouly, Khaled
Publicado: (2013)

Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer
por: Liu, Yuqing, et al.
Publicado: (2019)

Efficacy and safety of Bacillus Calmette-Guerin for bladder cancer: A protocol of systematic review
por: Zhang, Zhi-hui, et al.
Publicado: (2020)

Role of immunotherapy in Bacillus Calmette-Guérin unresponsive: non-muscle invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2020)

Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
por: Kim, Hyung Suk, et al.
Publicado: (2021)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Combination of Intravesical Chemotherapy and Bacillus Calmette–Guerin Versus Bacillus Calmette–Guerin Monotherapy in Intermediate- and High-risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis
por: Cui, Jianfeng, et al.
Publicado: (2016)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020)

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

Vertebral Osteomyelitis Secondary to Bacillus Calmette-Guérin Instillation Therapy for Transitional Cell Carcinoma In Situ
por: Jaber, Tariq M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ip3hif09mmv47femjrv4njpgqe